These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19098392)

  • 1. Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys.
    Kinugasa F; Nagatomi I; Ishikawa H; Nakanishi T; Maeda M; Hirose J; Fukahori H; Ooshima S; Noto T; Higashi Y; Seki N; Mutoh S
    J Pharmacol Sci; 2008 Dec; 108(4):529-34. PubMed ID: 19098392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
    Nakamura K; Oshima S; Maeda M; Morio H; Fukahori H; Nakanishi T; Tsujimoto S; Hirose J; Noto T; Hamakawa N; Inami M; Morokata T
    Int Immunopharmacol; 2018 Nov; 64():201-207. PubMed ID: 30195818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model.
    Dun H; Song L; Ma A; Hu Y; Zeng L; Bai J; Zhang G; Zhang L; Koide K; Okada Y; Hanaoka K; Yamamoto R; Hirose J; Morokata T; Daloze P; Chen H
    Transpl Immunol; 2017 Feb; 40():57-65. PubMed ID: 28077266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.
    Song L; Ma A; Dun H; Hu Y; Zeng L; Bai J; Zhang G; Kinugasa F; Sudo Y; Miyao Y; Okimura K; Miura T; Daloze P; Chen H
    Transplantation; 2014 Aug; 98(3):267-76. PubMed ID: 24992357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model.
    Kinugasa F; Nagatomi I; Nakanishi T; Noto T; Mori H; Matsuoka H; Sudo Y; Mutoh S
    Transpl Immunol; 2009 Sep; 21(4):198-202. PubMed ID: 19409992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
    Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients.
    Squifflet JP; Bäckman L; Claesson K; Dietl KH; Ekberg H; Forsythe JL; Kunzendorf U; Heemann U; Land W; Morales JM; Mühlbacher F; Talbot D; Taube D; Tyden G; van Hooff J; Schleibner S; Vanrenterghem Y;
    Transplantation; 2001 Jul; 72(1):63-9. PubMed ID: 11468536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation.
    Kwun J; Ezekian B; Manook M; Park J; Yoon J; Freischlag K; Song M; Farris AB; Sloan-Lancaster J; Fortier C; Rao PE; Knechtle SJ
    Transplantation; 2020 May; 104(5):970-980. PubMed ID: 32317615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
    Qi S; Zhu S; Xu D; Wang X; Ouyang J; Jiang W; Vu MD; Bilolo K; Ma A; Johnson S; Daloze P; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Apr; 75(8):1124-8. PubMed ID: 12717189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
    Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
    Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
    Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys.
    Chen G; Luke PP; Yang H; Visser L; Sun H; Garcia B; Qian H; Xiang Y; Huang X; Liu W; Senaldi G; Schneider A; Poppema S; Wang H; Jevnikar AM; Zhong R
    Am J Transplant; 2007 Jan; 7(1):27-37. PubMed ID: 17227555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
    Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
    Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey.
    Qi S; Xu D; Peng J; Vu MD; Wu J; Bekersky I; Fitzsimmons WE; Peets J; Sehgal S; Daloze P; Chen H
    Transplantation; 2000 Apr; 69(7):1275-83. PubMed ID: 10798741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys.
    Chen G; Sun H; Arp J; Garcia B; Wang X; Wise Y; Liu W; Ramcharran S; Huang X; Xiang Y; Yang H; Fang Z; Madrenas J; Sudo Y; Tamura K; Zhong R
    Am J Transplant; 2006 Apr; 6(4):714-23. PubMed ID: 16539628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.